Current Opinion in Supportive and Palliative Care

Papers
(The TQCC of Current Opinion in Supportive and Palliative Care is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Palliative care in COVID-1923
Bedside testing for precision pain medicine15
Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN)15
Social dimensions of chronic respiratory disease: stigma, isolation, and loneliness15
Pain in Parkinson's disease: Mechanism-based treatment strategies14
Cancer care disparities in the LGBT community14
New updates on transcranial magnetic stimulation in chronic pain14
Impact of COVID-19 on cancer screening: a global perspective13
Underlying conditions contributing to breathlessness in the population13
l-Menthol – a new treatment for breathlessness?11
Palliative and end-of-life care for the older adult with cancer10
Burden of respiratory problems in low-income and middle-income countries9
Methods for frailty screening and geriatric assessment in older adults with cancer8
Neuromodulation techniques for cancer pain management8
Intersectionality and heart failure: what clinicians and researchers should know and do8
Update on pain in arthritis7
Recent advances in artificial intelligence applications for supportive and palliative care in cancer patients7
The COVID-19 pandemic: challenges in providing supportive care to those with cardiovascular disease in a time of plague7
Palliative care delivery changes during COVID-19 and enduring implications in oncology nursing: a rapid review7
Serious health-related suffering and palliative care in South Asian countries7
Cancer care disparities among Australian and Aotearoa New Zealand Indigenous peoples7
Cardio-oncology: rationale, aims and future directions6
Unequal distribution of financial toxicity among people with cancer and its impact on access to care: a rapid review6
Measuring quality of life in older people with cancer6
Matters of care and the good death – rhetoric or reality?6
The burden and impact of chronic cough in severe disease6
Anamorelin in Japanese patients with cancer cachexia: an update6
The role of oncology pharmacists and comprehensive medication reconciliation in informing treatment plans for older adults with cancer and downstream outcomes5
Opioid use disorder in cancer patients5
A scoping review of unmet needs of caregivers of patients with pulmonary fibrosis5
Care needs of older patients with advanced cancer5
Metastasectomy in kidney cancer: current indications and treatment approaches5
Impact of the COVID-19 pandemic on care and psychological impact on cancer patients5
Impact of the coronavirus disease 2019 pandemic on delivery of and models for supportive and palliative care for oncology patients5
Tests to uncover and assess breathlessness: a proposed framework5
Finding value with prehabilitation in older persons receiving surgery4
Non-invasive ventilation support for people with amyotrophic lateral sclerosis: multidisciplinary team management4
The impact of coronavirus disease 2019 on medical assistance in dying4
Cachexia and bladder cancer: clinical impact and management4
Interventions to improve nutritional status for older patients with cancer – a holistic approach is needed4
Cognitive impairment in older adults with cancer4
Vitamin D is a potential treatment for the management of gastrointestinal mucositis4
Virtual geriatric and frailty assessment for older adults with cancer4
Cardiometabolic side effects of androgen deprivation therapy in prostate cancer4
Sexual dysfunction among adolescent and young adult cancer patients: diagnostic and therapeutic approach4
Cancer survivor late-effects, chronic health problems after cancer treatment: what’s the evidence from population and registry data and where are the gaps?4
Genetics in prostate cancer: implications for clinical practice4
Evolving role of minimally invasive techniques in the management of symptomatic bone metastases4
0.052230834960938